Dois-je éviter sassafras officinale bark/root extract pendant la grossesse ? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

sassafras officinale bark/root extract est-il sûr pendant la grossesse ?

Sassafras-derived materials can contain safrole, which has harmonised CLP classifications for carcinogenicity and genotoxicity (H350, H341) and is considered a carcinogen in governmental/agency reviews; this supports a high hazard score for reproductive/cancer-related risks in pregnancy when safrole is present. Sources note safrole as the main toxic constituent of sassafras oil. (ECHA; NTP; FDA).

sassafras officinale bark/root extract est-il sûr pendant l'allaitement ?

Same basis as pregnancy: presence of safrole (harmonised carcinogen/genotoxin) drives the hazard (H350/H341). Topical exposure to safrole-containing extracts can lead to systemic exposure at low but measurable levels, so breastfeeding exposure is plausible if safrole is present. (ECHA; NTP).

sassafras officinale bark/root extract est-il sûr pour la peau de bébé ?

Hazard remains driven by safrole content (harmonised carcinogen/genotoxin). Exposure score is increased by +1 for baby skin per your rules because sassafras constituents (safrole) are lipophilic and measurable; infant skin has higher absorption, so exposure is moderately higher than adult topical use. IFRA/Cosmetic guidance restricts safrole content in finished products. (IFRA summary; ECHA).

Comment VeriMom évalue-t-il sassafras officinale bark/root extract ?

VeriMom évalue sassafras officinale bark/root extract à 20/100 (risque élevé) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.

Quelles sont les alternatives sûres à sassafras officinale bark/root extract pendant la grossesse ?

Consultez notre liste d'alternatives sûres à sassafras officinale bark/root extract basée sur une fonction similaire et une classification sans risques connus.